You are viewing: China Life Science Analytics Market analysis
Part of: Life Science Analytics Market (Global)

The China Life Science Analytics Market was valued at $1892.8 Million in 2025 and projected to reach to $3862.6 Million by 2030, representing a compound annual growth rate of 15.3%. China's life science analytics market is poised for exceptional growth through 2030, driven by government initiatives supporting precision medicine, increasing healthcare digitalization, and rising investments in biotechnology research.

China Life Science Analytics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Life Science Analytics Market Trends and Insights

  • This represents a compound annual growth rate of 15.3%, significantly outpacing global market growth of 11.4%.
  • China's accelerating digital transformation in healthcare, coupled with substantial government investments in precision medicine and genomic research, is driving rapid adoption of advanced analytics solutions across pharmaceutical, biotechnology, and clinical research sectors. The Chinese market benefits from a large patient population, increasing healthcare expenditure, and regulatory support for innovation in life sciences.
  • China's emphasis on becoming a global leader in biotechnology and pharmaceutical development has catalyzed demand for sophisticated data analytics platforms that enable drug discovery, clinical trial optimization, and real-world evidence generation.
  • By 2030, China is expected to consolidate its position as a critical hub for life science analytics adoption in the Asia Pacific region, with growing integration of artificial intelligence and machine learning technologies..

Key Market Statistics

  • CAGR (2025-2030) 15.3% CAGR
  • Market Size, 2025 ~USD 1892.8 Million
  • Forecast, 2030 ~USD 3862.6 Million
  • Country China

China Life Science Analytics Market Overview

Rapid Market Expansion :

China's life science analytics market is projected to grow from USD 1,892.8 million in 2025 to USD 3,862.6 million by 2030, representing a 15.3% CAGR that significantly exceeds the global growth rate of 11.4%.

Government-Backed Precision Medicine :

Substantial government investments in precision medicine initiatives and digital health infrastructure are driving adoption of advanced analytics solutions across Chinese healthcare institutions and pharmaceutical companies.

Digital Healthcare Transformation :

China's accelerating digital transformation in healthcare, including AI integration and big data analytics, is creating unprecedented demand for life science analytics platforms among hospitals, research centers, and biotech firms.

Outpacing Global Growth :

With a 15.3% CAGR, China's life science analytics market is growing 3.9 percentage points faster than the global average, positioning it as one of the fastest-growing regional markets in the sector.

China Life Science Analytics Market Dynamics

  • The market's 15.3% CAGR reflects strong demand from pharmaceutical companies, clinical research organizations, and healthcare providers seeking data-driven insights for drug development and patient care optimization. The convergence of regulatory support, technological advancement, and healthcare modernization creates a favorable environment for analytics solution providers.
  • Chinese enterprises are increasingly adopting cloud-based analytics platforms and AI-powered tools to enhance research efficiency and clinical outcomes.
  • This trajectory positions China as a critical growth engine within the global life science analytics landscape..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • International Business Machines Corporation
  • EPIC SYSTEMS CORPORATION

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • China's life science analytics market will nearly double from USD 1,892.8M (2025) to USD 3,862.6M (2030), driven by 15.3% CAGR.
      • China's market growth rate of 15.3% significantly exceeds the global CAGR of 11.4%, positioning China as a high-growth market.
      • Government support for precision medicine and genomic research initiatives is accelerating analytics adoption across China's pharmaceutical and biotech sectors.
      • China's large patient population and rising healthcare investments create substantial demand for advanced data analytics in clinical research and drug development.

      Life Science Analytics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment PRESCRIPTIVE ANALYTICS (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 11.4% from 2025 to 2030
      Largest Segment SERVICES (Component)
      Market Size Base Year (Billions) ~USD 40.11 (2025)
      Revenue Forecast (Billions) ~USD 68.81 (2030)
      Segments Covered Type, Component, Service Type, Managed Service Type, Professional Service Type, Software Type, Application, Research & Development Application Type, Clinical Trial Type, Phase, Commercial Analytics Application Type, Safety Application Type, End User, Services Type

      China Life Science Analytics Market Report Segmentation

      14 segment dimensions are covered across the global market.

      By Type

      • Descriptive Analytics
      • Predictive Analytics
      • Prescriptive Analytics

      By Component

      • Services
      • Software

      By Service Type

      • Managed Services
      • Professional Services

      By Managed Service Type

      • Analytical Services
      • Consulting Services

      By Professional Service Type

      • Maintenance & Support Services
      • Other Profeessional Services
      • Other Professional Services
      • Other Professional Srvices
      • Other Professsional Services
      • Other Service Types
      • Patient Recruitment Services
      • Training & Implementation Services

      By Software Type

      • Cloud-Based
      • On-Premise
      • On-Premises
      • SaaS- Based
      • SaaS-Based
      • SaaS-S Based

      By Application

      • Commercial Analytics
      • Manufacturing & Supply Chain Optimization
      • Regulatory Compliance
      • Research & Development
      • Safety

      By Research & Development Application Type

      • Clinical Trials
      • Preclinical & Drug Discovery

      By Clinical Trial Type

      • Laboratory Services
      • Other Clinical Trial Servicces
      • Other Clinical Trial Services
      • Patient Recruitment Services
      • Site Identification Services

      By Phase

      • Phase I
      • Phase Ii
      • Phase Iii

      By Commercial Analytics Application Type

      • Engagement Services
      • Market Access
      • Rwe & Value Evidence
      • Sales & Marketing Support

      By Safety Application Type

      • Diagnostic Vigilance
      • Medical Device Safety
      • Pharmacovigilance

      By End User

      • Medical Device Companies
      • Outsourced Life Science Organizations
      • Pharmaceutical & Biotechnology Companies
      • Research Centers

      By Services Type

      • Managed Services
      • Professional Services

      CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      MEDICAL DEVICE COMPANIES612.8703.5805.9918.91046.81190.11350.11528.313.7
      OUTSOURCED LIFE SCIENCE ORGANIZATIONS402.1453.4510.3571.7639.8714.6796.5885.711.7
      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES968.31142.31344.81575.81844.72155.12512.42922.516.8
      RESEARCH CENTERS241.8273.9309.5348.2391.4438.9491.3548.712.1
      TOTAL22252573.12970.63414.63922.74498.75150.35885.214.7

      Target Audience

      • Pharmaceutical & Biotech Companies : Chinese and multinational pharma firms need market intelligence to optimize R&D investments, identify analytics technology partners, and capitalize on government precision medicine funding in China's expanding market.
      • Healthcare IT & Analytics Vendors : Software and analytics solution providers require China-specific market data to develop localized offerings, assess market entry feasibility, and benchmark against competitors in this 15.3% CAGR growth market.
      • Healthcare Institutions & Hospitals : Chinese hospitals and clinical research organizations need market insights to evaluate analytics platform investments, understand adoption trends, and align digital transformation strategies with market developments.
      • Investment & Private Equity Firms : Investors targeting China's healthcare sector require validated market sizing and growth projections to identify funding opportunities in life science analytics startups and established technology providers.
      • Government & Policy Makers : Chinese health authorities and policy organizations benefit from comprehensive market analysis to assess precision medicine initiative effectiveness, guide healthcare digitalization policies, and evaluate sector competitiveness.

      Key Companies in the China Life Science Analytics Market

      CompanyHQOwnershipStrongest segments
      BIOMERIEUX S.A.FrancePublic CompanyDescriptive Analytics,Predictive Analytics,Prescriptive Analytics,
      ALTENUnited StatesPublic CompanyDescriptive Analytics Services,Predictive Analytics & AI Services,Prescriptive Analytics & Optimization,
      UNISYS CORPORATIONUnited StatesPublic CompanyDescriptive Analytics Services,Predictive Analytics Services,Prescriptive Analytics & Optimization Services,
      LEIDOSUnited StatesPublic CompanyDescriptive Analytics Services,Predictive Analytics Services,Prescriptive Analytics Services,
      ORION HEALTH LTDNew ZealandPrivate CompanyDescriptive Analytics,Predictive Analytics,Prescriptive Analytics,
      DXC TECHNOLOGYUnited StatesPublic CompanyDescriptive Analytics,Predictive Analytics,Prescriptive Analytics,
      ORACLEUnited States
      VERADIGM LLCUnited StatesPublic CompanyDescriptive analytics,Predictive analytics,Prescriptive analytics,
      EXLSERVICE HOLDINGS, INC.United StatesPublic CompanyDescriptive Analytics,Predictive Analytics,Prescriptive Analytics,
      INOVALONUnited StatesPrivate CompanyDescriptive analytics,Predictive analytics,Prescriptive analytics,
      SAAMAUnited StatesPrivate CompanyPredictive & prescriptive clinical analytics,Descriptive clinical and operational analytics,RWE and outcomes analytics,

      BIOMERIEUX S.A.

      BioMérieux S.A. is a French public company founded in 1963 that specializes in in vitro diagnostics and microbiology testing solutions. With 14,894 employees, the company develops and manufactures diagnostic systems for clinical laboratories, pharmaceutical companies, and food safety applications.

      ALTEN

      ALTEN is a United States-based public company founded in 1988 that provides engineering and IT consulting services. With 56,376 employees, the company delivers technology solutions and professional services across multiple industries.

      UNISYS CORPORATION

      Unisys Corporation is a United States-based public company founded in 1873 that provides IT services, cloud solutions, and security services. With 15,000 employees, the company serves enterprise clients across government, financial services, and commercial sectors.

      LEIDOS

      Leidos is a United States-based public company founded in 1969 that provides engineering, IT, and scientific solutions primarily to government and commercial clients. With 50,000 employees, the company specializes in defense, intelligence, civil, and health sectors.

      ORION HEALTH LTD

      Orion Health Ltd is a New Zealand-based private company founded in 1993 that develops healthcare IT and clinical information systems software. With 1,000 employees, the company provides solutions for hospitals, health networks, and healthcare providers globally.

      DXC TECHNOLOGY

      DXC Technology is a United States-based public company founded in 1959 that provides IT services, consulting, and technology solutions to enterprise clients. With 115,000 employees, the company serves industries including finance, healthcare, manufacturing, and government.

      ORACLE

      Insufficient data available to generate description.

      VERADIGM LLC

      Veradigm LLC is a United States-based public company founded in 1986 that provides healthcare data and IT solutions. With 2,300 employees, the company delivers electronic health record systems, data analytics, and interoperability platforms for healthcare providers.

      EXLSERVICE HOLDINGS, INC.

      ExlService Holdings, Inc. is a United States-based public company founded in 1999 that provides business process management and IT services. With 65,000 employees, the company serves clients in healthcare, insurance, finance, and other industries.

      INOVALON

      Inovalon is a United States-based private company founded in 1998 that provides healthcare IT and data analytics solutions. With 1,836 employees, the company delivers cloud-based platforms and services for healthcare organizations and payers.

      SAAMA

      Saama is a United States-based private company founded in 1997 that provides data analytics and AI solutions for the life sciences and healthcare industries. The company delivers cloud-based platforms for clinical trials, real-world evidence, and healthcare analytics.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 1,892.8M in 2025) with verified 15.3% CAGR projections through 2030, enabling accurate investment decisions and competitive positioning in this high-growth market.
      • Competitive Intelligence : Understand China's market dynamics relative to global trends (11.4% CAGR), identifying competitive advantages and market gaps specific to Chinese healthcare providers, biotech firms, and analytics vendors.
      • Government Policy Insights : Access analysis of Chinese government precision medicine initiatives and digital health investments driving market expansion, critical for aligning product strategies with regulatory priorities and funding opportunities.
      • Segment & Application Analysis : Gain detailed breakdowns of China's life science analytics adoption across pharmaceutical R&D, clinical research, hospital systems, and genomics, enabling targeted market entry and product development strategies.
      • Strategic Planning & Forecasting : Leverage comprehensive 2025-2030 forecasts specific to China to guide resource allocation, partnership development, and expansion timelines in Asia's largest life science analytics opportunity.

      Frequently asked questions

      What is the projected size of China's life science analytics market by 2030?

      China's life science analytics market is projected to reach USD 3,862.6 million by 2030, growing from USD 1,892.8 million in 2025.

      What is the CAGR for China's life science analytics market?

      China's life science analytics market is expected to grow at a compound annual growth rate of 15.3% between 2025 and 2030.

      How does China's market growth compare to global growth?

      China's life science analytics market CAGR of 15.3% significantly outpaces the global CAGR of 11.4%, making China one of the fastest-growing markets.

      What factors are driving growth in China's life science analytics market?

      Key drivers include government investments in precision medicine, digital healthcare transformation, large patient populations, and regulatory support for pharmaceutical innovation in China.

      Which sectors in China are adopting life science analytics most rapidly?

      China's pharmaceutical, biotechnology, and clinical research sectors are leading adoption of life science analytics solutions for drug discovery and trial optimization.

      RESEARCH METHODOLOGY

      The study involved several key activities to estimate the current size of the life science analytics market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the life science analytics market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing life science analytics solutions is assessed using secondary data from both paid and free sources. This involves analyzing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

      The secondary research process involved referring to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of life science analytics vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

      Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

      After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of life science analytics solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Breakdown of Primary Respondents:

      Life Science Analytics Market

      Note 1: Others include sales, marketing, and product managers.

      Note 2: Tiers are defined based on a company’s total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by type, component, application, end user, and region).

      Life Science Analytics Market

      Data Triangulation

      After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the life science analytics market.

      Market Definition

      Life science analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models. Life science analytics tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for improved performance of life science organizations.

      Stakeholders

      • Pharmaceutical and biotechnology companies
      • Medical device companies
      • Contract research organizations (CROs)
      • Life science analytics vendors
      • Platform providers
      • Technology providers
      • System integrators
      • Healthcare IT service providers
      • Forums, alliances, and associations
      • Distributors
      • Government organizations
      • Academic research institutes
      • Institutional investors and investment banks
      • Investors/Shareholders
      • Venture capitalists
      • Research and consulting firms

      Report Objectives

      • To define, describe, and forecast the global life science analytics market based on type, component, application, end user, and region
      • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall life science analytics market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the life science analytics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
      • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the life science analytics market
      • To benchmark players within the life science analytics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

       

      Get the Full Life Science Analytics Market Report

      Full forecast, segment splits, and company analysis for all Life Science Analytics Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status